





When I posted my paper this morning, I was multi-tasking and hence forgot to include a paper by my European colleagues in Europe – the Fleishman-Hillard Brussels office specifically. That is home to a great blog called Public Affairs 2.0 … Continue reading
As any regular reader knows, I am a proponent of engagement in new media and have very strong concerns that the pharmaceutical industry is playing so sheepishly in this space that the industry is actually hobbling itself from a communications … Continue reading